Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Norihiro Ishii"'
Autor:
KENICHIRO ARAKI, NORIFUMI HARIMOTO, AKIRA WATANABE, MARIKO TSUKAGOSHI, NORIHIRO ISHII, KEI HAGIWARA, RYO MURANUSHI, KOUKI HOSHINO, TAKAOMI SEKI, KEN SHIRABE
Publikováno v:
Anticancer Research. 43:2273-2280
Autor:
Kenichiro, Araki, Norifumi, Harimoto, Kei, Shibuya, Akira, Watanabe, Mariko, Tsukagoshi, Norihiro, Ishii, Kei, Hagiwara, Ryo, Muranushi, Kouki, Hoshino, Takaomi, Seki, Ken, Shirabe
Publikováno v:
Anticancer Research. 43:209-216
The relationship between body composition including skeletal muscle and liver hypertrophy initiated by portal vein embolization (PVE) for major hepatectomy has not been clarified. This study aimed to investigate the effects of skeletal muscle, body a
Autor:
Norifumi, Harimoto, Shinji, Itoh, Takahiro, Yamanaka, Kei, Hagiwara, Norihiro, Ishii, Mariko, Tsukagoshi, Akira, Watanabe, Kenichiro, Araki, Tomoharu, Yoshizumi, Ken, Shirabe
Publikováno v:
Anticancer Research. 42:245-251
Mac2-binding protein glycosylation isomer (M2BPGi) is a non-invasive marker for assessing liver fibrosis. This was a retrospective study investigating whether M2BPGi predicts recurrence of hepatocellular carcinoma (HCC) after hepatectomy in patients
Autor:
Takamichi Igarashi, Kouki Hoshino, Ken Shirabe, Norihiro Ishii, Kei Hagiwara, Norifumi Harimoto, Mariko Tsukagoshi, Ryo Muranushi, Akira Watanabe, Kenichiro Araki, Norio Kubo
Publikováno v:
Anticancer Research. 40:4343-4349
Background We retrospectively investigated factors predictive for ascites after hepatic resection to treat hepatocellular carcinoma (HCC). Patients and methods The data of 114 patients with HCC who underwent curative hepatic resection were reviewed.
Autor:
Ryo Muranushi, Ken Shirabe, Norio Kubo, Hiroshi Tanaka, Hiroyasu Tomonaga, Tetsuya Higuchi, Norifumi Harimoto, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Yoshito Tsushima, Kenichirou Araki, Takahiro Yamanaka, Kei Hagiwara, Takamichi Igarashi, Kouki Hoshino
Publikováno v:
Anticancer Research. 39:971-977
BACKGROUND The aim of this study was to identify the prognostic impact of metabolic parameters of 18F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) in patients with intrahepatic cholangiocarcinoma (IHCC) undergoing hepatic resection. PA